Compare Alcon AG (ALC) vs JPMorgan Chase & Co (JPM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs JPMorgan Chase & Co — how do they compare? Alcon AG trades at $66.64 (market cap $32.69B), while JPMorgan Chase & Co trades at $330.5 (market cap $908.94B). The key difference: JPMorgan Chase & Co is far larger — about 27.8× Alcon AG's market cap, and JPMorgan Chase & Co pays the higher dividend (1.77%). Which is the better fit depends on your goals.
| ALC | JPM | |
|---|---|---|
Market Cap | $32.69B | $908.94B |
Sector | Health | Financials |
52-Week High | $92.22 | $339.22 |
52-Week Low | $62.02 | $282.78 |
Enterprise Value | $36.28B | — |
Dividend Yield | 0.54% | 1.77% |
Volume | — | 10,479,943 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
JPMorgan Chase & Co. (JPM) trades at $330.48, down 2.14% today, amid a bullish technical outlook with moving averages signaling strength. The stock shows solid fundamentals with 2025 revenue of $181.85B and net income of $57.05B, though cash flow trends remain volatile. Recent earnings beat expectations in Q1 2026 with EPS of $5.94, and analyst consensus is a Moderate Buy with a $360.38 price target. CEO Jamie Dimon's shareholder letter highlights economic risks, while institutional activity includes mixed positioning changes.
JPMorgan presents a favorable investment case driven by strong profitability, high ROE of 17.03%, and analyst optimism, but faces headwinds from geopolitical tensions, cybersecurity threats, and fluctuating cash flows. The stock's upside to the consensus target offers potential, yet investors must weigh macroeconomic uncertainties and sector-specific challenges highlighted in recent news.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About JPMorgan Chase & Co
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →
